EpiVax, Inc. - Informatics and Immunology
  • Our Company
    • Company Overview
    • Corporate Responsibility
    • Mission, Vision & Values
    • Team
    • Careers
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • BioDefense Vaccines
    • Tregitope: Immunomodulation Power Tool
    • Deimmunization Projects
  • Vaccine Services
    • Vaccine Services
    • iVAX: Web-based Vaccine Design
    • PreVAX Analysis
    • EpiCC
  • Immunogenicity Assessment
    • Immunogenicity Assessment Overview
    • ISPRI Web-based Immunogenicity Assessment
    • PreDeFT Analysis
    • JanusMatrix Analysis
    • High Throughput Antibody Immunogenicity Analysis
    • PANDA Screening
    • ISPRI for Host Cell Proteins
    • Deimmunization
    • Trusted Expert Advice (TEA) Consulting Services
  • Lab Services
    • Lab Services Overview
    • HLA Binding Assays
    • In Vitro Immunization Protocol (IVIP)
  • Press Room
    • Press Room
    • Events
      • Webinars
    • Publication & Poster Search
    • Client Testimonials
    • Thinking Out Loud (Blog)
    • Recipes For Success (Podcast)
  • Contact Us
Select Page
Structure-guided Immunogen Design: Modulating B cell and T cell Immunogenicity of First and Second Generation H7N9 Vaccines

Structure-guided Immunogen Design: Modulating B cell and T cell Immunogenicity of First and Second Generation H7N9 Vaccines

by Annie De Groot | Mar 20, 2019

ACVR immune engineering poster 2019_20Mar2019_930am
Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali

Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali

by Annie De Groot | Mar 1, 2019

Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine

Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine

by Annie De Groot | Feb 15, 2019

Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine

Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi

by Annie De Groot | Jan 7, 2019

https://www.tandfonline.com/doi/full/10.1080/21645515.2018.1560772
Modeling HLA Binding and “Self” Conservation Using In Silico Tools Predicts Immunogenic T Cell Epitopes in Vaccinated Individuals

Modeling HLA Binding and “Self” Conservation Using In Silico Tools Predicts Immunogenic T Cell Epitopes in Vaccinated Individuals

by Annie De Groot | Oct 9, 2018

EpiVax_ISV2018_HLA Binding and Self Conservation_4Oct18
« Older Entries
Next Entries »

Recent Posts

  • Platform shoes, Bellbottoms and #CrueltyFreeFDA!
  • EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool: CircoMatch™
  • EpiVax, Inc. Subsidiary, EpiVax Therapeutics Signs Exclusive Collaboration Agreement with GreenLight Biosciences to Develop Personalized Cancer Vaccines
  • #VaxGivesBack and 2022 Charitable Giving
  • EpiVax 2.0 and … Matching your Philanthropy!

Categories

  • EpiVax Immunoncology
  • Events
  • Featured
  • News
  • Recipes for Success – Vlog
  • Thinking Out Loud -Blog
  • Uncategorized
  • Webinars

Discover

  • Vaccine Services
  • Immunogenicity Assessment
  • Deimmunization
  • Lab Services
  • Pipeline

About

  • Our Company
  • Press Room
  • Events
  • Publication & Poster Search
  • Thinking Out Loud (Blog)
  • Contact Us

Connect

© 2023 EpiVax, Inc. – Informatics and Immunology, All rights reserved. Privacy Policy • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 • fax: 401.272.7562